NCT07066657
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07066657
Title A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ArriVent BioPharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
ULCA NOT_YET_RECRUITING Los Angeles California 90095 United States Details
UCSF NOT_YET_RECRUITING San Francisco California 94158 United States Details
University of Colorado NOT_YET_RECRUITING Aurora Colorado 80010 United States Details
Sarah Cannon Research Institute NOT_YET_RECRUITING Denver Colorado 80218 United States Details
Sarah Cannon Research Institute NOT_YET_RECRUITING Sarasota Florida 34232 United States Details
Sarah Cannon Research Institute NOT_YET_RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
NEXT Dallas NOT_YET_RECRUITING Irving Texas 75039 United States Details
NEXT Virginia NOT_YET_RECRUITING Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center NOT_YET_RECRUITING Seattle Washington 98109 United States Details
Peking University Cancer Hospital RECRUITING Beijing Beijing Municipality 100142 China Details
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology ACTIVE_NOT_RECRUITING Wuhan Hubei China Details
Hunan Cancer Hospital ACTIVE_NOT_RECRUITING Changsha Hunan China Details
Renji Hospital Shanghai Jiaotong University School of Medicine RECRUITING Shanghai Shanghai Municipality China Details
Zhongshan Hospital Fudan University RECRUITING Shanghai Shanghai Municipality China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field